↓ Skip to main content

Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma

Overview of attention for article published in Journal of Translational Medicine, January 2015
Altmetric Badge

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma
Published in
Journal of Translational Medicine, January 2015
DOI 10.1186/1479-5876-13-s1-o6
Pubmed ID
Authors

Georgina V Long, Victoria Atkinson, Paolo A Ascierto, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier, Jessica C. Hassel, Piotr Rutkowski, Catriona McNeil, Ewa Kalinka-Warzocha, Kerry J. Savage, Micaela Hernberg, Celeste Lebbé, Julie Charles, Catalin Mihalcioiu, Vanna Chiarion-Sileni, Cornelia Mauch, Henrik Schmidt, Dirk Schadendorf, Helen Gogas, Christine Horak, Brian Sharkey, Ian M. Waxman, Caroline Robert

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 33%
Student > Ph. D. Student 2 11%
Professor > Associate Professor 2 11%
Student > Master 2 11%
Student > Bachelor 1 6%
Other 3 17%
Unknown 2 11%
Readers by discipline Count As %
Medicine and Dentistry 9 50%
Biochemistry, Genetics and Molecular Biology 2 11%
Agricultural and Biological Sciences 2 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Psychology 1 6%
Other 1 6%
Unknown 2 11%